Mira Pharmaceuticals (MIRA) Cash & Current Investments (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Cash & Current Investments of $11.0 million for Q4 2025, up 46.37% sequentially from $7.5 million in Q3 2025, and up 289.35% YoY from $2.8 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Cash & Current Investments (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Cash & Current Investments data on file, last reported at $11.0 million in Q4 2025.
- Quarterly Cash & Current Investments rose 289.35% year-over-year to $11.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.0 million (up 289.35% YoY) and the FY2025 annual result came in at $11.0 million, up 289.35% from the prior year.
- Cash & Current Investments rose to $11.0 million in Q4 2025 per MIRA's latest filing, from $7.5 million in the prior quarter.
- The five-year high for Cash & Current Investments was $11.0 million in Q4 2025, with the low at $1349.0 in Q1 2023.
- Average Cash & Current Investments over 4 years is $3.2 million, with a median of $2.8 million recorded in 2024.
- Year-over-year, Cash & Current Investments surged 259351.45% in 2024 and slumped 65.53% in 2025.
- Mira Pharmaceuticals' Cash & Current Investments stood at $350978.0 in 2022, then soared by 1211.35% to $4.6 million in 2023, then slumped by 38.45% to $2.8 million in 2024, then jumped by 289.35% to $11.0 million in 2025.
- Business Quant data shows MIRA's Cash & Current Investments at $11.0 million in Q4 2025, $7.5 million in Q3 2025, and $730475.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 5.28 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 22.05 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 9.39 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 7.94 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 5.70 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 7.64 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 13.08 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 100.00 Mn |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | 11.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.03 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 730,475.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 4.60 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | 24,823.00 |
| Mar 31, 2023 | 1,349.00 |
| Dec 31, 2022 | 350,978.00 |
| Sep 30, 2022 | 187,415.00 |